Does thyroid-stimulating hormone influence the prognosis of patients with endometrial cancer? A multicentre trial

V. Seebacher,G. Hofstetter,S. Polterauer,A. Reinthaller,C. Grimm,R. Schwameis,S. Taucher,A. Wagener,C. Marth,N. Concin

Published 2013 in British Journal of Cancer

ABSTRACT

Background:Thyroid function has been suggested to interfere with tumour biology and prognosis in different cancers. The present study was performed to investigate the impact of pre-therapeutic serum thyroid-stimulating hormone (TSH) levels on the prognosis of patients with endometrial cancer.Methods:Pre-therapeutic serum TSH was investigated in 199 patients with endometrial cancer. After stratification in TSH risk groups, univariate and multivariable survival analyses were performed.Results:Elevated TSH was independently associated with poor disease-specific survival in univariate/multivariable survival analyses (P=0.01 and P=0.03, respectively).Conclusion:Thyroid-stimulating hormone may serve as a novel and independent prognostic parameter for disease-specific survival in patients with endometrial cancer.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-21 of 21 references · Page 1 of 1

CITED BY

Showing 1-20 of 20 citing papers · Page 1 of 1